Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amr Elkholy

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Pharmacy and Pharmacology Research|October 28, 2022
Age-Dependent Heterogeneity of Lymph Node Metastases and Survival Identified by Analysis of a National Breast Cancer RegistryMichael Behring, Prachi Bajpai, Farrukh Afaq, et al.
Open Access Macedonian Journal of Medical Sciences|July 10, 2018
Upregulation of Twist2 in Non-Muscle Invasive Urothelial Carcinoma of the Bladder Correlate with Response to Treatment and ProgressionMohamed Wishahi, Heba Khalil, Mohamed H Badawy, et al.
Arab Journal of Urology|September 29, 2015
Laparoscopic management of distal ureteric stones in a bilharzial ureter: Results of a single-centre prospective studyHani H Nour, Samir E Elgobashy, Amr Elkholy, et al.
Journal of the Egyptian Society of Parasitology|October 22, 2015
LAPAROSCOPIC MANAGEMENT OF DISTAL URETERIC STONE IN BILHARZIAL URETER: RESULTS OF A SINGLE CENTER PROSPECTIVE STUDYHani H Nour, Samir E Elgobashy, Amr Elkholy, et al.
Translational Oncology|September 20, 2021
Corrigendum to 'Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model' [Translational Oncology 13 (2020) 100754]Sumit Agarwal, Michael Behring, Hyung-Gyoon Kim, et al.
Translational Oncology|March 22, 2020
Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX ModelSumit Agarwal, Michael Behring, Hyung-Gyoon Kim, et al.
Cancer Medicine|June 30, 2021
Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistentMichael Behring, Yuanfan Ye, Amr Elkholy, et al.
Molecular Oncology|February 23, 2022
DCZ0415, a small-molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β-catenin pathway in colorectal cancerSumit Agarwal, Farrukh Afaq, Prachi Bajpai, et al.
Pathology, Research and Practice|April 26, 2025
Defining molecular signatures of the solid/pseudopapillary and pseudoglandular patterns in so-called "solid-tubulocystic intrahepatic cholangiocarcinoma vs. NIPBL::NACC1 fusion hepatic carcinoma"Prachi Bajpai, Fatme Ghandour, Ekta Jain, et al.
Acta Neuropathologica Communications|June 28, 2025
Xenoline-polarized macrophages as an alternative in vitro model of tumor-associated macrophages in glioblastomaHasan Alrefai, Benjamin Lin, Amr Elkholy, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Pharmacy and Pharmacology Research|October 28, 2022
Age-Dependent Heterogeneity of Lymph Node Metastases and Survival Identified by Analysis of a National Breast Cancer RegistryMichael Behring, Prachi Bajpai, Farrukh Afaq, et al.
Open Access Macedonian Journal of Medical Sciences|July 10, 2018
Upregulation of Twist2 in Non-Muscle Invasive Urothelial Carcinoma of the Bladder Correlate with Response to Treatment and ProgressionMohamed Wishahi, Heba Khalil, Mohamed H Badawy, et al.
Arab Journal of Urology|September 29, 2015
Laparoscopic management of distal ureteric stones in a bilharzial ureter: Results of a single-centre prospective studyHani H Nour, Samir E Elgobashy, Amr Elkholy, et al.
Journal of the Egyptian Society of Parasitology|October 22, 2015
LAPAROSCOPIC MANAGEMENT OF DISTAL URETERIC STONE IN BILHARZIAL URETER: RESULTS OF A SINGLE CENTER PROSPECTIVE STUDYHani H Nour, Samir E Elgobashy, Amr Elkholy, et al.
Translational Oncology|September 20, 2021
Corrigendum to 'Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model' [Translational Oncology 13 (2020) 100754]Sumit Agarwal, Michael Behring, Hyung-Gyoon Kim, et al.
Translational Oncology|March 22, 2020
Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX ModelSumit Agarwal, Michael Behring, Hyung-Gyoon Kim, et al.
Cancer Medicine|June 30, 2021
Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistentMichael Behring, Yuanfan Ye, Amr Elkholy, et al.
Molecular Oncology|February 23, 2022
DCZ0415, a small-molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β-catenin pathway in colorectal cancerSumit Agarwal, Farrukh Afaq, Prachi Bajpai, et al.
Pathology, Research and Practice|April 26, 2025
Defining molecular signatures of the solid/pseudopapillary and pseudoglandular patterns in so-called "solid-tubulocystic intrahepatic cholangiocarcinoma vs. NIPBL::NACC1 fusion hepatic carcinoma"Prachi Bajpai, Fatme Ghandour, Ekta Jain, et al.
Acta Neuropathologica Communications|June 28, 2025
Xenoline-polarized macrophages as an alternative in vitro model of tumor-associated macrophages in glioblastomaHasan Alrefai, Benjamin Lin, Amr Elkholy, et al.
Pageof 3